Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px
Document › Details

Affimed N.V.. (5/22/19). "Press Release: Affimed Announces R&D Strategy to Focus on Innate Immunity Portfolio, Reports First Quarter 2019 Financial Results and Operational Progress". Heidelberg.

Organisations Organisation Affimed N.V. (Nasdaq: AFMD)
  Group Affimed (Group)
  Organisation 2 Genentech Inc.
  Group Roche (Group)
Products Product AFM11 (Affimed)
  Product 2 AFM13 (Affimed)
Persons Person Hoess, Adi (Affimed 201109– CEO before CCO before Jenowis + Jerini 2003– + Carl Zeiss AG + MorphoSys AG)
  Person 2 Gin, Gregory (Affimed 201808 Head of Investor Relations)
     


   
Record changed: 2019-05-31

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x112px

More documents for Affimed (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSBNL] Life-Sciences-Benelux.com – The Business Web Portal 600x86px




» top